CELL-TYPE-SPECIFIC AND LIGAND SPECIFIC ENHANCEMENT OF CELLULAR UPTAKE OF OLIGODEOXYNUCLEOSIDE METHYLPHOSPHONATES COVALENTLY-LINKED WITH A NEOGLYCOPEPTIDE, YEE(AH-GALNAC)(3)

被引：59

作者：

HANGELAND, JJ ^{[1
]}

LEVIS, JT ^{[1
]}

LEE, YC ^{[1
]}

TSO, POP ^{[1
]}

机构：

[1] JOHNS HOPKINS UNIV, DEPT BIOL, BALTIMORE, MD 21218 USA

来源：

BIOCONJUGATE CHEMISTRY | 1995年 / 6卷 / 06期

关键词：

D O I：

10.1021/bc00036a006

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

A novel, structurally defined, and homogeneous oligodeoxynucleoside methylphosphonate (oligo-MP) neoglycopeptide conjugate, [YEE(ah-GalNAc)(3)]-SMCC-AET-pU(m)pT(7), has been synthesized. The linkage between the carbohydrate ligand and the oligo-MP is a metabolically stable thioether. Experiments establish that uptake of this conjugate by human hepatocellular carcinoma (Hep G2) is cell-type specific when compared with its uptake by human fibrosarcoma (HT 1080) and human promyleocytic leukemia (HL-60). Uptake of the conjugate with Hep G2 cells can be totally inhibited by the addition of a 100-fold excess of free YEE(ah-GalNAc)(3) in the culture medium indicating the observed cell uptake is ligand specific. The conjugate is rapidly taken in by Hep G2 cells in a linear fashion reaching a saturation plateau of 26 pmol per 10(6) cells after 24 h. Conjugation of oligo-MPs to ligands for hepatic carbohydrate receptors, such as YEE(ah-GalNAc)(3), represents an efficient and ligand-specific method for the intracellular delivery of oligo-MPs.

引用

页码：695 / 701

页数：7

共 35 条

[11] ANTIVIRAL EFFECT OF OLIGO(NUCLEOSIDE METHYLPHOSPHONATES) COMPLEMENTARY TO THE HERPES-SIMPLEX VIRUS TYPE-1 IMMEDIATE EARLY MESSENGER RNA-4 AND MESSENGER RNA-5 [J].

KULKA, M ;

WACHSMAN, M ;

MIURA, S ;

FISHELEVICH, R ;

MILLER, PS ;

TSO, POP ;

AURELIAN, L .

ANTIVIRAL RESEARCH, 1993, 20 (02) :115-130

[12] SYNERGISTIC ANTIVIRAL ACTIVITIES OF OLIGONUCLEOSIDE METHYLPHOSPHONATES COMPLEMENTARY TO HERPES SIMPLES VIRUS TYPE-1 IMMEDIATE-EARLY MESSENGER RNA-4, RNA-5, AND RNA-1 [J].

KULKA, M ;

SMITH, CC ;

LEVIS, J ;

FISHELEVICH, R ;

HUNTER, JCR ;

CUSHMAN, CD ;

MILLER, PS ;

TSO, POP ;

AURELIAN, L .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) :675-680

[13] SITE SPECIFICITY OF THE INHIBITORY EFFECTS OF OLIGO(NUCLEOSIDE METHYLPHOSPHONATE)S COMPLEMENTARY TO THE ACCEPTOR SPLICE JUNCTION OF HERPES-SIMPLEX VIRUS TYPE-1 IMMEDIATE EARLY MESSENGER RNA-4 [J].

KULKA, M ;

SMITH, CC ;

AURELIAN, L ;

FISHELEVICH, R ;

MEADE, K ;

MILLER, P ;

TSO, POP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) :6868-6872

[14] INDUCTION OF CHRONIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IS BLOCKED INVITRO BY A METHYLPHOSPHONATE OLIGODEOXYNUCLEOSIDE TARGETED TO A U3 ENHANCER ELEMENT [J].

LAURENCE, J ;

SIKDER, SK ;

KULKOSKY, J ;

MILLER, P ;

TSO, POP .

JOURNAL OF VIROLOGY, 1991, 65 (01) :213-219

[15]

LEAMON CP, BRIT J CANCER, V463, P94

[16] PREPARATION OF CLUSTER GLYCOSIDES OF N-ACETYLGALACTOSAMINE THAT HAVE SUBNANOMOLAR BINDING CONSTANTS TOWARDS THE MAMMALIAN HEPATIC GAL GALNAC-SPECIFIC RECEPTOR [J].

LEE, RT ;

LEE, YC .

GLYCOCONJUGATE JOURNAL, 1987, 4 (04) :317-328

[17] TARGETED DELIVERY OF DNA USING YEE(GALNACAH)(3), A SYNTHETIC GLYCOPEPTIDE LIGAND FOR THE ASIALOGLYCOPROTEIN RECEPTOR [J].

MERWIN, JR ;

NOELL, GS ;

THOMAS, WL ;

CHIOU, HC ;

DEROME, ME ;

MCKEE, TD ;

SPITALNY, GL ;

FINDEIS, MA .

BIOCONJUGATE CHEMISTRY, 1994, 5 (06) :612-620

[18]

MILLER PS, 1981, BIOCHEMISTRY-US, V20, P1874, DOI 10.1021/bi00510a024

[19]

MILLER PS, 1991, OLIGONUCLEOTIDES ANA, P137

[20]

MIRABELLI CK, 1993, ANTISENSE RES APPL, P7

← 1 2 3 4 →